Genetic Modification Therapies Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: GD84B56A585FEN
Market Monitor Global

Abstracts

Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.

This report contains market size and forecasts of Genetic Modification Therapies in Global, including the following market information:

Global Genetic Modification Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Genetic Modification Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gene Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Genetic Modification Therapies include 4D Molecular Therapeutics, Abeona Therapeutics, Allergan, American Gene Technologies, Merck Millipore and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genetic Modification Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Genetic Modification Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Genetic Modification Therapies Market Segment Percentages, by Type, 2021 (%)

• Gene Therapies
• Genetically Modified Cell Therapies
• RNA Therapies
• Gene Editing

Global Genetic Modification Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Genetic Modification Therapies Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostics and Testing Laboratories
• Academic and Research Organizations
• Others

Global Genetic Modification Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Genetic Modification Therapies Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Genetic Modification Therapies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Genetic Modification Therapies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 4D Molecular Therapeutics
• Abeona Therapeutics
• Allergan
• American Gene Technologies
• Merck Millipore
• AbbVie

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Genetic Modification Therapies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Genetic Modification Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENETIC MODIFICATION THERAPIES OVERALL MARKET SIZE

2.1 Global Genetic Modification Therapies Market Size: 2021 VS 2028
2.2 Global Genetic Modification Therapies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Genetic Modification Therapies Players in Global Market
3.2 Top Global Genetic Modification Therapies Companies Ranked by Revenue
3.3 Global Genetic Modification Therapies Revenue by Companies
3.4 Top 3 and Top 5 Genetic Modification Therapies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genetic Modification Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genetic Modification Therapies Players in Global Market
  3.6.1 List of Global Tier 1 Genetic Modification Therapies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Genetic Modification Therapies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Genetic Modification Therapies Market Size Markets, 2021 & 2028
  4.1.2 Gene Therapies
  4.1.3 Genetically Modified Cell Therapies
  4.1.4 RNA Therapies
  4.1.5 Gene Editing
4.2 By Type - Global Genetic Modification Therapies Revenue & Forecasts
  4.2.1 By Type - Global Genetic Modification Therapies Revenue, 2017-2022
  4.2.2 By Type - Global Genetic Modification Therapies Revenue, 2023-2028
  4.2.3 By Type - Global Genetic Modification Therapies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Genetic Modification Therapies Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostics and Testing Laboratories
  5.1.4 Academic and Research Organizations
  5.1.5 Others
5.2 By Application - Global Genetic Modification Therapies Revenue & Forecasts
  5.2.1 By Application - Global Genetic Modification Therapies Revenue, 2017-2022
  5.2.2 By Application - Global Genetic Modification Therapies Revenue, 2023-2028
  5.2.3 By Application - Global Genetic Modification Therapies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Genetic Modification Therapies Market Size, 2021 & 2028
6.2 By Region - Global Genetic Modification Therapies Revenue & Forecasts
  6.2.1 By Region - Global Genetic Modification Therapies Revenue, 2017-2022
  6.2.2 By Region - Global Genetic Modification Therapies Revenue, 2023-2028
  6.2.3 By Region - Global Genetic Modification Therapies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Genetic Modification Therapies Revenue, 2017-2028
  6.3.2 US Genetic Modification Therapies Market Size, 2017-2028
  6.3.3 Canada Genetic Modification Therapies Market Size, 2017-2028
  6.3.4 Mexico Genetic Modification Therapies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Genetic Modification Therapies Revenue, 2017-2028
  6.4.2 Germany Genetic Modification Therapies Market Size, 2017-2028
  6.4.3 France Genetic Modification Therapies Market Size, 2017-2028
  6.4.4 U.K. Genetic Modification Therapies Market Size, 2017-2028
  6.4.5 Italy Genetic Modification Therapies Market Size, 2017-2028
  6.4.6 Russia Genetic Modification Therapies Market Size, 2017-2028
  6.4.7 Nordic Countries Genetic Modification Therapies Market Size, 2017-2028
  6.4.8 Benelux Genetic Modification Therapies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Genetic Modification Therapies Revenue, 2017-2028
  6.5.2 China Genetic Modification Therapies Market Size, 2017-2028
  6.5.3 Japan Genetic Modification Therapies Market Size, 2017-2028
  6.5.4 South Korea Genetic Modification Therapies Market Size, 2017-2028
  6.5.5 Southeast Asia Genetic Modification Therapies Market Size, 2017-2028
  6.5.6 India Genetic Modification Therapies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Genetic Modification Therapies Revenue, 2017-2028
  6.6.2 Brazil Genetic Modification Therapies Market Size, 2017-2028
  6.6.3 Argentina Genetic Modification Therapies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Genetic Modification Therapies Revenue, 2017-2028
  6.7.2 Turkey Genetic Modification Therapies Market Size, 2017-2028
  6.7.3 Israel Genetic Modification Therapies Market Size, 2017-2028
  6.7.4 Saudi Arabia Genetic Modification Therapies Market Size, 2017-2028
  6.7.5 UAE Genetic Modification Therapies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 4D Molecular Therapeutics
  7.1.1 4D Molecular Therapeutics Corporate Summary
  7.1.2 4D Molecular Therapeutics Business Overview
  7.1.3 4D Molecular Therapeutics Genetic Modification Therapies Major Product Offerings
  7.1.4 4D Molecular Therapeutics Genetic Modification Therapies Revenue in Global Market (2017-2022)
  7.1.5 4D Molecular Therapeutics Key News
7.2 Abeona Therapeutics
  7.2.1 Abeona Therapeutics Corporate Summary
  7.2.2 Abeona Therapeutics Business Overview
  7.2.3 Abeona Therapeutics Genetic Modification Therapies Major Product Offerings
  7.2.4 Abeona Therapeutics Genetic Modification Therapies Revenue in Global Market (2017-2022)
  7.2.5 Abeona Therapeutics Key News
7.3 Allergan
  7.3.1 Allergan Corporate Summary
  7.3.2 Allergan Business Overview
  7.3.3 Allergan Genetic Modification Therapies Major Product Offerings
  7.3.4 Allergan Genetic Modification Therapies Revenue in Global Market (2017-2022)
  7.3.5 Allergan Key News
7.4 American Gene Technologies
  7.4.1 American Gene Technologies Corporate Summary
  7.4.2 American Gene Technologies Business Overview
  7.4.3 American Gene Technologies Genetic Modification Therapies Major Product Offerings
  7.4.4 American Gene Technologies Genetic Modification Therapies Revenue in Global Market (2017-2022)
  7.4.5 American Gene Technologies Key News
7.5 Merck Millipore
  7.5.1 Merck Millipore Corporate Summary
  7.5.2 Merck Millipore Business Overview
  7.5.3 Merck Millipore Genetic Modification Therapies Major Product Offerings
  7.5.4 Merck Millipore Genetic Modification Therapies Revenue in Global Market (2017-2022)
  7.5.5 Merck Millipore Key News
7.6 AbbVie
  7.6.1 AbbVie Corporate Summary
  7.6.2 AbbVie Business Overview
  7.6.3 AbbVie Genetic Modification Therapies Major Product Offerings
  7.6.4 AbbVie Genetic Modification Therapies Revenue in Global Market (2017-2022)
  7.6.5 AbbVie Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Genetic Modification Therapies Market Opportunities & Trends in Global Market
Table 2. Genetic Modification Therapies Market Drivers in Global Market
Table 3. Genetic Modification Therapies Market Restraints in Global Market
Table 4. Key Players of Genetic Modification Therapies in Global Market
Table 5. Top Genetic Modification Therapies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genetic Modification Therapies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genetic Modification Therapies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genetic Modification Therapies Product Type
Table 9. List of Global Tier 1 Genetic Modification Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Modification Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genetic Modification Therapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genetic Modification Therapies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genetic Modification Therapies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genetic Modification Therapies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genetic Modification Therapies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genetic Modification Therapies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genetic Modification Therapies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genetic Modification Therapies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genetic Modification Therapies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genetic Modification Therapies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genetic Modification Therapies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genetic Modification Therapies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genetic Modification Therapies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genetic Modification Therapies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genetic Modification Therapies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genetic Modification Therapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genetic Modification Therapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genetic Modification Therapies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genetic Modification Therapies Revenue, (US$, Mn), 2023-2028
Table 30. 4D Molecular Therapeutics Corporate Summary
Table 31. 4D Molecular Therapeutics Genetic Modification Therapies Product Offerings
Table 32. 4D Molecular Therapeutics Genetic Modification Therapies Revenue (US$, Mn), (2017-2022)
Table 33. Abeona Therapeutics Corporate Summary
Table 34. Abeona Therapeutics Genetic Modification Therapies Product Offerings
Table 35. Abeona Therapeutics Genetic Modification Therapies Revenue (US$, Mn), (2017-2022)
Table 36. Allergan Corporate Summary
Table 37. Allergan Genetic Modification Therapies Product Offerings
Table 38. Allergan Genetic Modification Therapies Revenue (US$, Mn), (2017-2022)
Table 39. American Gene Technologies Corporate Summary
Table 40. American Gene Technologies Genetic Modification Therapies Product Offerings
Table 41. American Gene Technologies Genetic Modification Therapies Revenue (US$, Mn), (2017-2022)
Table 42. Merck Millipore Corporate Summary
Table 43. Merck Millipore Genetic Modification Therapies Product Offerings
Table 44. Merck Millipore Genetic Modification Therapies Revenue (US$, Mn), (2017-2022)
Table 45. AbbVie Corporate Summary
Table 46. AbbVie Genetic Modification Therapies Product Offerings
Table 47. AbbVie Genetic Modification Therapies Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Genetic Modification Therapies Segment by Type in 2021
Figure 2. Genetic Modification Therapies Segment by Application in 2021
Figure 3. Global Genetic Modification Therapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genetic Modification Therapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genetic Modification Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genetic Modification Therapies Revenue in 2021
Figure 8. By Type - Global Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 12. US Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 16. Germany Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 17. France Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 24. China Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 28. India Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 30. Brazil Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genetic Modification Therapies Revenue Market Share, 2017-2028
Figure 33. Turkey Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genetic Modification Therapies Revenue, (US$, Mn), 2017-2028
Figure 37. 4D Molecular Therapeutics Genetic Modification Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abeona Therapeutics Genetic Modification Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Allergan Genetic Modification Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. American Gene Technologies Genetic Modification Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Millipore Genetic Modification Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AbbVie Genetic Modification Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)